Retailers News South Africa

Dis-Chem profit rises on new acquisitions, medicine demand

Dis-Chem Pharmacies reported a rise in annual profit on Monday, 23 May, buoyed by acquisitions of new drugstores and stronger demand for medicines as Covid-19 lockdowns ease.
Source: Dis-Chem
Source: Dis-Chem

The pharmacy retail chain said the acquisitions of dozens of locations during the year ended 28 February, and its recent launch of a health insurance offering have helped the group broaden its focus.

"In the two months since launching medical insurance, uptake has exceeded our initial expectations," Dis-Chem said in a statement, although it warned the consumer environment remained "constrained."

Dis-Chem, which runs the second-largest chain of pharmacies in South Africa in competition with Clicks Group, said it administered 1.4 million Covid-19 vaccine doses during the year, resulting in R513m in revenue.

Total revenue climbed 15.7% to R30.4bn. Headline earnings per share, a key metric of profit for South African companies, jumped 27.6% to 99.2 cents for the year.

Source: Reuters

Reuters, the news and media division of Thomson Reuters, is the world's largest multimedia news provider, reaching billions of people worldwide every day.

Go to:

About Muhammed Husain

Reporting by Muhammed Husain in Bengaluru; Editing by Subhranshu Sahu

Let's do Biz